Mission Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Hold
4,800
0.02% 304
2025
Q4
$993K Buy
+4,800
New +$949K 0.02% 335
2025
Q3
Hold
0
-$1.34M 728
2025
Q2
Hold
0
271
2025
Q1
Hold
0
229
2024
Q4
Hold
0
237
2024
Q3
Hold
0
-$468K 699
2024
Q2
Hold
0
424
2024
Q1
Hold
0
443
2023
Q4
Hold
0
184
2023
Q3
Hold
0
146
2023
Q2
Hold
0
138
2023
Q1
Hold
0
127
2022
Q4
Hold
0
131
2022
Q3
Hold
0
125
2022
Q2
Sell
-2,000
Closed -$356K 115
2022
Q1
$354K Hold
2,000
0.02% 378
2021
Q4
$342K Hold
2,000
0.02% 404
2021
Q3
$323K Sell
2,000
-2,000
-50% -$341K 0.02% 393
2021
Q2
$659K Buy
+4,000
New +$662K 0.03% 238

Other funds holding JNJ

Mission Wealth Management's JNJ Position: Q1 2026 in Review

Mission Wealth Management reduced its Johnson & Johnson (JNJ) stake by 16% in Q1 2026, selling an estimated $2.49M and leaving 54,271 shares worth $13.3M. The position accounts for 0.27% of the portfolio, ranked #58.

Mission Wealth Management first reported a position in JNJ in Q2 2015 and has held it in 44 quarters since. The position peaked at $13.9M in Q4 2021. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Mission Wealth Management held 54,271 shares of Johnson & Johnson worth $13.3M as of Q1 2026.
  • Mission Wealth Management sold 10,697 Johnson & Johnson shares in Q1 2026, an estimated $2.49M.
  • Johnson & Johnson made up 0.27% of Mission Wealth Management's portfolio in Q1 2026, its #58 holding.
  • Mission Wealth Management first reported a position in Johnson & Johnson in Q2 2015 and has held it in 44 quarters since.
  • Mission Wealth Management's Johnson & Johnson position peaked at $13.9M in Q4 2021.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Mission Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.